Morgan Lewis advised Integra LifeSciences Holdings Corporation in a definitive agreement to acquire Acclarent from Ethicon, a Johnson & Johnson company, for $275 million in cash at closing.
Integra LifeSciences is a global medical technology company delivering treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. Acclarent is a medical device company supporting ear, nose, and throat (ENT) surgeons delivering minimally invasive technologies.
Morgan Lewis partners Benjamin Wills, Conor Larkin, and Peter Watt-Morse and associates Erin O’Gurek and Matthew Sherman are representing Integra LifeSciences.
Original source can be found here.